Notice of Early Expiration of RFA-AI-21-020, “Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)"
Notice Number:
NOT-AI-22-053

Key Dates

Release Date:

August 22, 2022

Related Announcements

RFA-AI-21-020 - Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed)

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

The purpose of this Notice is to inform the extramural community of the early expiration of RFA-AI-21-020, Early-Stage Development of Data Science Technologies for Infectious and Immune-mediated Diseases (U01 Clinical Trial Not Allowed), effective immediately. The Key Dates section of the FOA has been modified to change the Expiration Date from July 7, 2023 to August 22, 2022.

NIAID is preparing a new, similar FOA that will be published in the near future. Applicants are encouraged to monitor the NIH Guide.

Currently Reads:
 

Part 1. Overview Information

Key Dates

Posted Date

March 17, 2021
 

Open Date (Earliest Submission Date)

June 02, 2021


Letter of Intent Due Date(s)

30 days prior to the application due date
 

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

July 02, 2021

July 02, 2021

July 02, 2021

November 2021

January 2022

March 2022

February 17, 2022

February 17, 2022

February 17, 2022

July 2022

October 2022

December 2022

July 01, 2022

July 01, 2022

July 01, 2022

November 2022

January 2023

March 2023

February 17, 2023

February 17, 2023

February 17, 2023

July 2023

October 2023

December 2023

July 06, 2023

July 06, 2023

July 06, 2023

November 2023

January 2024

March 2024


All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).


Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


Expiration Date

July 07, 2023


Due Dates for E.O. 12372

Not Applicable

Modified to Read:

Part 1. Overview Information

Key Dates

Posted Date

March 17, 2021
 

Open Date (Earliest Submission Date)

June 02, 2021


Letter of Intent Due Date(s)

30 days prior to the application due date
 

Application Due Dates

Review and Award Cycles

New

Renewal / Resubmission / Revision (as allowed)

AIDS

Scientific Merit Review

Advisory Council Review

Earliest Start Date

July 02, 2021

July 02, 2021

July 02, 2021

November 2021

January 2022

March 2022

February 17, 2022

February 17, 2022

February 17, 2022

July 2022

October 2022

December 2022

July 01, 2022

July 01, 2022

July 01, 2022

November 2022

January 2023

March 2023

February 17, 2023

February 17, 2023

February 17, 2023

July 2023

October 2023

December 2023

July 06, 2023

July 06, 2023

July 06, 2023

November 2023

January 2024

March 2024


All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).


Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.


Expiration Date

July 07, 2023 August 22, 2022

Due Dates for E.O. 12372

Not Applicable

Inquiries

Please direct all inquiries to:

Office of Data Science and Emerging Technologies (ODSET)
National Institute for Allergy and Infectious Diseases (NIAID)
Email: datascience-foa@niaid.nih.gov